New advice has been issued by the Nursing and Midwifery Council (NMC) to help nurses and midwives who administer or prescribe injectable cosmetic products such as Botox.
Clinicians working in the area are being advised to consult ‘Remote prescribing and injectable cosmetic medicinal products’, which sets out the NMC’s position that remote prescriptions or directions to administer should not be used to administer injectable cosmetic medicinal products such as botulinum toxin (Botox).
Developed in partnership with the Royal College of Nursing (RCN), the advice has been drawn up in response to the increasing numbers of nurses and midwives who work independently, perhaps in their own practice.
NMC director of policy and standards, Roger Thompson said: “I would strongly urge nurses and midwives working in aesthetic practice to read this advice in conjunction with the NMC’s Standards for Medicines Management.
“As the regulator for the UK’s 660,000 nurses and midwives, we are committed to safeguarding the public. This advice will support the registered nurses and midwives working in the field of aesthetic practice to make their local policies are fully compliant with the standards.”
Head of RCN Nursing Department, Steve Jamieson, said: “It was important for the RCN to be involved in the development of this advice as we represent a large number of members who work in this growing area of nursing. I recommend that all staff working in this field read the advice.”
Have you signed our petition to ensure nurses have a seat on consortia boards? Follow @Aseatontheboard on twitter follow for all the latest campaign news!